Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver. 2003

Shintaro Fumoto, and Fumi Nakadori, and Shigeru Kawakami, and Makiya Nishikawa, and Fumiyoshi Yamashita, and Mitsuru Hashida
Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.

OBJECTIVE To determine the intrahepatic disposition characteristics of galactosylated liposome/plasmid DNA (pDNA) complexes in perfused rat liver. METHODS Galactosylated liposomes containing N-[1-(2,3-dioleyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA), cholesterol (Chol), and cholesten-5-yloxy-N-14-[(1-imino-2-D-thiogalactosylethyl)amino]butyl] formamide (Gal-C4-Chol) were prepared. The liposome/[32P]-labeled pDNA complexes were administered to perfused liver, and the venous outflow patterns were analyzed based on a two-compartment dispersion model. RESULTS The single-pass hepatic extraction of pDNA complexed with DOTMA/Chol/Gal-C4-Chol liposomes was greater than that with control DOTMA/Chol liposomes. A two-compartment dispersion model revealed that both the tissue binding and cellular internalization rate were higher for the DOTMA/Chol/Gal-C4-Chol liposome complexes compared with the control liposome complexes. The tissue binding was significantly reduced by the presence of 20 mM galactose. When their cellular localization in the perfused liver at 30 min postinjection was investigated, it was found that the parenchymal uptake of the DOTMA/Chol/Gal-C4-Chol liposome complexes was greater than that of the control liposome complexes. The parenchymal cell/ nonparenchymal cell uptake ratio was as high as unity. CONCLUSIONS Galactosylation of the liposome/pDNA complexes increases the tissue binding and internalization rate via an asialoglycoprotein receptor-mediated process. Because of the large particle size of the complexes (approximately 150 nm), however, penetration across the fenestrated sinusoidal endothelium appears to be limited.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D002412 Cations Positively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis. Cation
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005690 Galactose An aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. Deficiency of galactosyl-1-phosphate uridyltransferase (GALACTOSE-1-PHOSPHATE URIDYL-TRANSFERASE DEFICIENCY DISEASE) causes an error in galactose metabolism called GALACTOSEMIA, resulting in elevations of galactose in the blood. D-Galactose,Galactopyranose,Galactopyranoside,D Galactose

Related Publications

Shintaro Fumoto, and Fumi Nakadori, and Shigeru Kawakami, and Makiya Nishikawa, and Fumiyoshi Yamashita, and Mitsuru Hashida
January 2003, Drug metabolism and pharmacokinetics,
Shintaro Fumoto, and Fumi Nakadori, and Shigeru Kawakami, and Makiya Nishikawa, and Fumiyoshi Yamashita, and Mitsuru Hashida
November 1995, Journal of pharmaceutical sciences,
Shintaro Fumoto, and Fumi Nakadori, and Shigeru Kawakami, and Makiya Nishikawa, and Fumiyoshi Yamashita, and Mitsuru Hashida
September 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
Shintaro Fumoto, and Fumi Nakadori, and Shigeru Kawakami, and Makiya Nishikawa, and Fumiyoshi Yamashita, and Mitsuru Hashida
February 2000, Biochimica et biophysica acta,
Shintaro Fumoto, and Fumi Nakadori, and Shigeru Kawakami, and Makiya Nishikawa, and Fumiyoshi Yamashita, and Mitsuru Hashida
October 2007, Analytical chemistry,
Shintaro Fumoto, and Fumi Nakadori, and Shigeru Kawakami, and Makiya Nishikawa, and Fumiyoshi Yamashita, and Mitsuru Hashida
January 1998, Journal of controlled release : official journal of the Controlled Release Society,
Shintaro Fumoto, and Fumi Nakadori, and Shigeru Kawakami, and Makiya Nishikawa, and Fumiyoshi Yamashita, and Mitsuru Hashida
June 2001, Journal of drug targeting,
Shintaro Fumoto, and Fumi Nakadori, and Shigeru Kawakami, and Makiya Nishikawa, and Fumiyoshi Yamashita, and Mitsuru Hashida
July 2004, International journal of pharmaceutics,
Shintaro Fumoto, and Fumi Nakadori, and Shigeru Kawakami, and Makiya Nishikawa, and Fumiyoshi Yamashita, and Mitsuru Hashida
January 1998, Journal of pharmaceutical sciences,
Shintaro Fumoto, and Fumi Nakadori, and Shigeru Kawakami, and Makiya Nishikawa, and Fumiyoshi Yamashita, and Mitsuru Hashida
September 1977, Toxicology and applied pharmacology,
Copied contents to your clipboard!